A structural biologist from the University of Bath has received a £240,000 grant to develop an improved, single-dose vaccine against bovine tuberculosis (bTB).

Jean van den Elsen
Dr Jean van den Elsen. Photo: University of Bath.

Jean van den Elsen, a structural biologist from the university’s department of biology and biochemistry, received the award from the Biotechnology and Biological Sciences Research Council (BBSRC) Follow-on Funding programme.

The programme supports translating scientific research funded by the BBSRC into practical applications, and aims to help researchers “maximise the societal and economic benefits” of their research.

Dr van den Elsen developed a vaccine technology in collaboration with Andrew Watts from the university’s department of pharmacy and pharmacology and Kevin Marchbank from Newcastle University Medical School.

Vaccination potential

Their research is based on the discovery a new protein developed in Dr van den Elsen’s laboratory stimulated an immune response that protects against pathogens, such as TB bacterium Mycobacterium tuberculosis.

Initial experiments have been promising and the team believes the protein has the potential to be incorporated into a safe and effective single-dose vaccine, reducing vaccination costs and increasing protection against the disease, which kills millions of people and livestock every year and causes severe economic damage worldwide.

syringe
Dr van den Elsen’s technology could reduce vaccination costs and increasing protection against bTB. Image: ellisia / Fotolia.

Over the next 18 months, the team will focus on targeting bTB to demonstrate the effectiveness and value of their work.

Attempts to control bTB in England alone have cost £500 million in the past 10 years.

Improving protection

Dr van den Elsen said the team was delighted to have received the award and is grateful to the BBSRC.

He said: “Worldwide bTB can cause severe economic losses from livestock deaths, chronic disease and trade restrictions.

“We’re aiming to improve a vaccine’s ability to be given on a single dose basis and improve rates of protection, which would vastly reduce vaccination costs and provide increased safety.”

In addition, the technology involved in this research could help address needs in areas including autoimmune disease and cancer.

View your activity >

Leave a Reply

Be the First to Comment!

Notify of
avatar

wpDiscuz

related content

The leg of a two-year-old Münsterländer dog has been saved from amputation using medical technology funded by Sir Bobby Charlton’s landmine charity, Find A Better Way.

6 mins

The old will blend with the new at the Scottish Vet Fair 2017, when cutting-edge technology and advances in clinical practice will be showcased inside a 16th century castle.

3 mins

Veterinary courses can now be considered as “long course” degrees in England, therefore increasing the loan available to students.

6 mins

The importance of the human-companion animal bond was explored at the sixth Centre for Agriculture and Bioscience International (CABI)-RVC Symposium on Animal Welfare and Behaviour.

4 mins

Lee-Anne Oliver discusses methods of controlling various forms of this condition and how to prevent it spreading among flocks.

25 mins

Alex Gough runs his eye over more innovations in the veterinary world, in his latest Research Review.

12 mins